GlassScriptPhysician profile
Thomas Kryzak
NPI 1861604548
$7,249.42
in general payments reported to CMS, 2019-2025
9 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,130 · 2020: $981 · 2021: $637 · 2022: $1,476 · 2023: $1,732 · 2024: $1,080 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,025.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,513.72 | 2019-2024 | Mako, T2 Alpha, Actishield |
| Zimmer Biomet Holdings, INC. | $1,942.56 | 2020-2025 | Persona, Rosa, G7 Osseoti Acetabular Shell |
| Depuy Synthes Sales INC. | $1,051.30 | 2020-2025 | Attune, Velys, Actis |
| Smith+Nephew, INC. | $900.69 | 2021-2024 | Journey II |
| Encore Medical, LP | $251.01 | 2019 | |
| Ortho Development Corporation | $215.38 | 2019 | |
| Maxx Orthopedics, INC. | $185.31 | 2023 | |
| Anika Therapeutics, INC. | $148.53 | 2022 | |
| Innovation Technologies INC | $40.92 | 2023 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Kryzak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.